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Abstract
Good knowledge on the disease situation and its impact on production is a base 
mechanism for designing health surveillance, risk analysis and biosecurity systems. 
Mediterranean marine fish farming, as any aquaculture production, is affected by 
various infectious diseases. However, seabass and seabream, the main produced spe-
cies, are not listed as susceptible host species for the notifiable pathogens listed in 
the current EU legislation, which generates a lack of systematic reporting. The results 
presented in this study come from a survey directly to fish farms (50 hatchery and 
on-growing units from 10 Mediterranean countries), with data from 2015 to 2017, 
conducted by the H2020 project MedAID. Seabass showed a higher survival rate 
(85%) through a production cycle than seabream (80%) in spite of equal mortality 
due to pathogen infections (10%). The differences in survival may be explained by 
mortality ‘of other causes’. Seabream and seabass have different disease profiles, and 
the profile is slightly different between geographical regions. Among the most impor-
tant diseases, tenacibaculosis and vibriosis were identified in seabass and Sparicotyle 
chrysophrii (a gill fluke) and nodavirus in seabream. Correlating mortality data to man-
agement variables showed that increasing density, buying fingerlings from external 
sources and treatments due to disease are factors that negatively influence mortality 
rate. Most of the surveyed farms did not keep sufficient quality data to implement 
good health status reports and perform detailed impact studies, which shows the ne-
cessity of updating the current legislative framework to provide the basis for better 
reporting of relevant pathogens in the Mediterranean basin.
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1  | INTRODUC TION
Intensive production of European seabass (Dicentrarchus labrax) and 
Gilthead seabream (Sparus aurata) in the Mediterranean is a relatively 
young industry that began in the late 80s, grew exponentially in the 
90s and has continued its expansion during the following two decades. 
Although the sector has faced several crises, the production increased 
every year during the 2011–2017 period, from 268,952 tonnes in 2011 
to 426,744 tonnes in 2017 (FAO, 2018). About 90% of the seabass and 
seabream production is concentrated in 6 countries: Turkey (37%), 
Greece (25%), Egypt (14%), Spain (9%), Tunisia (4%) and Italy (4%).
As well as in livestock production, the aquaculture sector is vul-
nerable to exotic, endemic and emerging diseases (FAO, 2018). Good 
knowledge on the disease situation and its impact on production is 
a base mechanism for designing of health surveillance, risk analy-
sis and biosecurity systems. Disease is one of the major reasons for 
trade barriers on aquaculture products and live fish (e.g. Alam & 
Tomossy, 2017; Håstein et al., 2008) and constrains the expansion of 
the aquaculture industry worldwide.
As regards seabass and seabream farming, most of the knowl-
edge describing diseases in the sector comes from references about 
diagnosed outbreaks of different pathogens and subsequent re-
search on different related aspects, that is, epidemiology, patho-
gen characterization, diagnostic methods, development of vaccines 
(Vendramin et al., 2016). Reviews or analysis about disease problems 
or health status by fish species at the regional level are scarce and 
based on bibliography analysis and/or consultation with fish pathol-
ogists, for example, Rodgers and Furones (1998), the EU-project 
PANDA 2007 and have been presented in specialized conferences, 
that is, EAFP. Vendramin et al. (2016) from the Workshop on ‘Fish 
health in Mediterranean Aquaculture, past mistakes and future 
challenges’ held at the 17thEAFP Conference (Las Palmas 2015) 
referred to nodavirus, Vibrio anguillarum, Photobacterium damselae 
subps. Piscicida and gill flukes, as the most important problems in 
Mediterranean mariculture.
Being aware of the need of having a better knowledge of the 
health status of Mediterranean marine fish farming, the European 
Union Reference Laboratory (EURL) for Fish Diseases makes, 
since 2012, an annual analysis, through a consultation with fish 
pathologists, to follow trends and highlight emergence of new fish 
diseases in the Mediterranean. The aim of this initiative is to set 
up a platform that can link authorities and stakeholders aiming to 
target the main sanitary issues in the basin and focus future re-
search activities on these topics (EURL Fish 2018). More recently, 
the Federation of Veterinarians of Europe (FVE) established in 
December 2015 the FishMed + Coalition, with the aim of getting 
more information about critical fish diseases for which few au-
thorised or no treatment options are available (De Briyne, 2017). 
Moreover, according to FVE, there is a need to prevent further use 
of non-authorized products. Consequently, the current situation 
poses a serious constraint on the prevention and treatment of dis-
eases, leading to welfare problems and hampering the growth of 
Mediterranean Aquaculture.
MedAID (Mediterranean Aquaculture Integrated Development) 
is a four-year project, funded by the European Union in the frame 
of Horizon 2020, grant agreement number 727315. The overar-
ching goal of MedAID is to increase the overall competitiveness 
and sustainability of the Mediterranean marine fish-farming sec-
tor, throughout the whole value chain. Currently, Mediterranean 
aquaculture is lacking or has fragmented knowledge on epidemi-
ology, impact of diseases, harmonized and coordinated diagnos-
tics, or strategies and tools for a proper local, regional or even 
Pan Mediterranean health management. One of the project work 
packages is health management and diseases and fish welfare ad-
dresses these issues of improving disease management by using 
risk assessment tools for relevant new and emerging pathogens in 
the Mediterranean basin.
This present study is part of a multidisciplinary sustainability 
assessment of Mediterranean marine fish-farming sector, con-
ducted to obtain an integrated view of the sector, including an 
analysis of the economic background, zootechnical and fish health 
problems, product development and marketing and governance 
issues. The analysis was performed through a series of surveys 
directly conducted to fish farms managers and/or technical per-
sonnel in ten countries, with the aim to gain further knowledge 
directly from the producers.
The results presented in this study are part of the work aiming to 
describe mortality rates, disease occurrence and distribution based 
on farmers own records data of existing diseases at a regional scale 
and their impact on production.
2  | MATERIAL S AND METHODS
The data in this study come from a sustainability assessment of 
the Mediterranean marine fish-farming sector, conducted at the 
beginning of the H2020 project MedAID, during the year 2018. 
The assessment was implemented through a holistic multidisci-
plinary survey designed by the Institute of Agrifood Research and 
Technology (IRTA), together with leaders of other project thematic 
Work packages. The survey was structured into different question-
naires, including zootechnical, environmental, social, diseases and 
health management, economic and governance information. The 
contents of the questionnaire on diseases and health management 
were designed by the Norwegian Veterinary Institute, NVI (leader 
of Work package on Health management and diseases and fish wel-
fare), in collaboration with the rest of partners participating in that 
WP. It covered questions on-farm information, production data, 
management practices and biosecurity, disease occurrence, diagnos-
tics, management and reporting. Interviewees were asked to report 
data for the period 2015 to 2017, with monthly disease diagnoses 
data requested.
To carry out the survey, a Data Collection Working Group (DCWG) 
was established with MedAID partners, from the different participat-
ing countries. The group was trained by IRTA through web seminars 
and video calls to collect the requested data, in a homogenous way, 
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through face to face interviews, taking into account the characteris-
tics of each country and company. In order to get the required data, 
different experts from each company were interviews. For the sec-
tion on diseases and health management, the interviews required the 
participation of the company expert in charge of those issues, either a 
veterinarian, a health manager or the production manager.
All the information obtained from the companies participating 
in the survey was processed, while maintaining the principle of 
confidentiality and privacy, to guarantee the use of the data, with-
out compromising personal data protection regulations. Once the 
surveys were completed, a database was established and the data 
analysed.
Briefly, 50 production units belonging to 27 companies from 
10 Mediterranean countries, both from European Union (Croatia, 
Cyprus, France, Greece, Italy, Portugal and Spain) and Non-European 
Union (Egypt, Tunisia and Turkey) were surveyed. The seabass and 
seabream production of these 10 countries represents more than 
95% of the whole production in the Mediterranean. Although, there 
are no available statistics about the number of production units the 
MedAID project assessment showed that the number of on-growing 
operating farms is estimated to be around 950, and the number of 
marine hatcheries to be 91. The companies to be surveyed were se-
lected not only to cover the maximum number of countries produc-
ing seabass and seabream in the region, but also to include different 
company structures.
To preserve confidentiality (geographic location and farm 
profile) of participating companies during the mapping analy-
sis, the Mediterranean area was divided into five regions: central 
Mediterranean (Adriatic coast of Italy, Greece and Croatia), east-
ern Mediterranean (Turkey and Cyprus), southern Mediterranean 
(Tunisia and Egypt), western Mediterranean (Tyrrhenian coast of 
Italy, France & Spain) and outer Mediterranean (Portugal and Atlantic 
Spain and France).
Data management and statistical analyses were performed using 
R (R Core Team, 2019). Differences in survival and mortality levels 
between sea bass and sea bream were assessed using the Mann–
Whitney U test. A p-value < .05 was considered statistically signif-
icant. As the assessment of the data by Kolmogorov–Smirnov test 
showed left skewness, median was chosen as the mid-value for use 
in the analyses.
3  | RESULTS
3.1 | Description of study population
A total of 50 production units (31 with on-growing, 16 with hatch-
ery or nursery and three with processing plants) from 27 com-
panies, located in 10 Mediterranean countries (Croatia, Cyprus, 
Egypt, France, Greece, Italy, Portugal, Spain, Tunisia and Turkey), 
participated in the survey. Nine additional companies were con-
tacted and refused to participate in this study. All hatchery and 
nursery culture was under intensive conditions with different 
water sources, and the majority of the on-growing was intensive 
production in sea cages, except for three units that reported to 
use lagoon, natural resurgence and water from lake and river as 
their water source.
Table 1 shows the number of production units from which dis-
eases were reported, by region. Thirty-eight production units out of 
the 50 surveyed units reported the occurrence of one or more dis-
ease events during the survey period; 27 sea bass production units 
(15 on-growing, 9 hatcheries and 3 pre-growing) and 11 sea bream 
production units (9 on-growing and 2 hatcheries).
3.2 | Disease situation in Mediterranean seabass, 
seabream farms based on survey
Bacterial infections dominated the reports (75.0%) for sea bass, 
while parasitic infections (57.0%) were the most frequently reported 
infections in sea bream. When performing a more detailed catego-
rization of the reported diseases, as well as categorizing the report-
ing units by production type, there appear to be some differences 
between the two fish species (Table 2).
Vibriosis (Vibrio sp.) was the most frequently reported bac-
terial infection in sea bass in the on-growing phase, followed by 
tenacibaculosis and photobacteriosis. Vibriosis was reported from 
all stages throughout the production chain, while tenacibaculosis 
and photobacteriosis seem to be more problematic for on-growing 
sites. Viral encephalopathy and retinopathy-Viral nervous necro-
sis (VER-VNN) was the only viral infection reported in sea bass 
production, occurring mainly in the on-growing phase with a low 
TA B L E  1   Overview of the production units that reported diseases in the survey during 2015 to 2017
 
Sea bass Sea bream
On-growing Hatchery Pre-growing Growing Hatchery Pre-growing
Central Mediterranean 3 1 0 3 0 0
Eastern Mediterranean 4 3 2 2 0 0
Western Mediterranean 3 4 1 2 2 0
Southern Mediterranean 4 1 0 2 0 0
Outer Mediterranean 1 0 0 0 0 0
Total 15 9 3 9 2 0
Note: The units are divided according to fish species, unit type and Mediterranean region.
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number of reports from the hatchery phase. A number of different 
parasitic infestations were reported; however, all were reported 
to have a low level of occurrence. Parasitic infestations that had 
more than one reported case included non-specified crustacean 
infestation in the on-growing phase and Sparicotyle (gill fluke) in 
the hatchery phase.
As for sea bream production, the most frequently reported dis-
ease was caused by Sparycotyle chrysophrii (gill fluke) which is affect-
ing production in the on-growing stage. It is also worth noting the 
‘Winter Syndrome’, another frequently reported disease problem 
at this production stage, frequently affecting sea bream during the 
period January to May during all three years covered by the survey. 
Bacterial infections are mostly reported from hatcheries, with vibriosis 
being most common. VER-VNN seems to cause minor problems for 
sea bream production and was reported from the hatchery phase only.
The monthly time series of the major diseases are presented in 
Figure 1 (sea bass) and Figure 2 (sea bream). While there is a gen-
eral seasonality of the occurrence of some diseases in both species, 
overall sea bream shows a lower reported disease occurrence (over-
all and monthly number of reported disease cases) than sea bass.
Vibrio sp. infection was present throughout the year and was a 
dominant infection in sea bass while it was less of a problem for sea 
bream. Tenacibaculosis (also known as flexibacteriosis) was the sec-
ond most reported disease for sea bass and was reported through-
out the year in 2017. This was in contrast to 2016 when there were 
no reports during the summer months (July–August).
VER-VNN occurs during the spring for sea bream while it is a sum-
mer–autumn disease for sea bass. The occurrence seems to be quite 
stable through these three years of study for sea bass while there 
is no registration of VER-VNN for sea bream in 2017; however, the 
results should be interpreted in the light of the short duration of our 
study.
3.3 | Mortality patterns
The median survival percentage of surveyed farms during on-grow-
ing phase was found to be 85.0% and 80.0% for sea bass and sea 
bream, respectively (Table 3), while the median disease-related mor-
tality rate was 10.0% for both species (Table 3).
The only statistically significant difference in mortality between 
the two species was found for mortality by other causes (refer to 
non-pathogen infections), with median sea bass mortality (5.0%) 
being significantly lower than that of the sea bream (10.0%).
3.4 | Impact on the mortality of selected diseases
A wide range in mortality was observed for diseases affecting 
farmed sea bass. The reported mortality associated with Vibrio 
sp. infection, ranged from 0.003% to 4.00% in sea bass on-grow-
ing units, while it was higher in both hatchery units (0.2%–10.0%) 
TA B L E  2   Overview of the number of disease records for the survey units over a 3 years period (2015–2017), categorized by pathogen 
and production unit type
 
Sea bass
 
Sea bream
On-
growing Hatchery
Pre-
growing
Total 
sum
On-
growing Hatchery
Pre-
growing
Total 
sum
Bacteria Bacteria
Vibrio sp. 68 (11) 15 (4) 12 (1) 95 Vibrio sp.  8 (1)  8
Tenacibaculosis 23 (4) 9 (2)  32 Photobacteriosis 2 (1) 1 (1)  3
Photobacteriosis 24 (2)  1 (1) 25 Tenacibaculosis  3 (1)  3
Aeromona sp.  1 (1)  1 Virus
Virus VER-VNN  5 (1)  5
VER-VNN 22 (4) 2 (1)  24 Lymphocystis 3 (1) 1 (1)  4
Parasite Parasite
Crustacean 3 (1)   3 Sparicotyle 70 (7)   70
Sparicotyle  3 (1)  3 Dactylogyrus 3 (1)   3
Amyloodimium 1 (1)   1 Cryptocarion  2 (1)  2
Dactylogyrus 1 (1)   1 Enteromyxum 1 (1)   1
Trichodines  1 (1)  1 Other
Other Winter Syndrome 16 (3)   16
Not significant 
pathologies
18 (5) 2 (1) 3 (1) 23 Not significant 
pathologies
 2 (1) 3 (1) 5
Malformations  4 (1)  4 Red Rash 4 (1)   4
Canibalism  2 (1)  2      
Note: The number of production units from which each disease was reported is given in parenthesis.
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and pre-growing units (0.2%–5.0%). A similar pattern was seen for 
tenacibaculosis, with 0.5%–5.0% being reported in on-growing 
units while both hatchery and pre-growing units reported maxi-
mum mortality level of 14.0%, with the median mortality level 
being four times that of the on-growing units. For Photobacteriosis 
the mortality levels ranged from 0.80% for hatchery units to 
5.5% in pre-growing units. VER-VNN was only reported in the 
on-growing phase and mortality levels ranged from 0.1% to 7.5% 
while the median observed mortality level was 2.0%.
For sea bream, there were generally lower levels of mortality as-
sociated with diseases with all medians being at 1.00%; however, for 
Sparicotyle mortalities up to 30.00% were reported. No information 
was available in relation to other factors that might have contributed 
to such a high level of mortality.
F I G U R E  1   Monthly records of the four most common diseases reported for 27 sea bass farms from 2015 to 2017. Vibrio sp., 
Tenacibaculosis, Photobacteriosis, VER-VNN were reported for 95, 32, 25 and 24 times respectively during the survey period (total number 
of reports = 215)
F I G U R E  2   Monthly records of the four most common diseases reported for 11 sea bream from 2015 to 2017. Sparicotylosis, 
Winter Syndrome, Vibrio sp., VER-VNN were reported for 70, 16, 8 and 5 times respectively during the survey period (total number of 
reports = 124)
6  |     MUNIESA Et Al.
3.5 | Hatchery and pre-growing production units
A total of 10 hatcheries from Croatia, Cyprus, France, Greece, Spain, 
Tunisia and Turkey participated in the study. Data on 61 batches of 
fingerlings (33 for sea bass and 28 for sea bream) were available. The 
number of batches per production unit was relatively stable, ranging 
from 1 to 7 batches per unit in 2015, 1–6 batches in 2016 and 1–5 
batches in 2017. With respect to the live fish origin, the majority of 
broodstock (72.0%) was self-cultured, while 28.0% were bought. For 
larvae origin, 62.0%, 30.0% and 8.0% were self-cultured, bought and 
from both sources, respectively.
The main water sources for the hatcheries were borehole (60.0%), 
lagoon (21.0%), estuarine (8.00%) and open seawater (5.0%). As for 
the treatment of inlet waters, 88.0% reported using one or both of 
the following methods: mechanical filtration and ultraviolet radia-
tion (UV). Amongst the 12.0% that reported no treatment for inlet 
water, all had borehole as their water source. No information was 
available on the treatment of outlet water.
Only three pre-growing production units participated in the sur-
vey. Borehole and open seawater were indicated as the source of 
inlet waters in two out of three units, but no water treatment was 
applied at either unit. The unit that failed to report on water inlet 
source indicated using both filtration and UV treatment.
Due to a limited number of hatcheries and pre-growing units that 
reported disease occurrence, further analyses of the data were not 
possible.
3.6 | On-growing production units
The survey data contained information on 136 fish batches, of which 
74 were contained sea bass, 62 contained sea bream and one being a 
mix of both species. These batches were reared in 20 on-growing units 
from June 2013 to September 2017. The majority of the production 
was on-growing open sea cages, except for three units that reported 
to use lagoon, natural resurgence and water from lake and river as their 
water source. No physicochemical water treatment was applied except 
for one recirculation aquaculture systems (RAS) unit that reported 
using ozone treatment with 15.0%–20.0% daily water exchange. About 
76.0% of juveniles were self-cultured, and 24.0% were bought.
The initial size of juveniles ranged from 1 to 100 g for sea bass, 
and from 2 to 40 g for sea bream. These were graded either by au-
tomatic or manual procedures. A few did not perform any grading. 
Fifty-eight per cent of the sea bass went through some kind of treat-
ment, while the figure for sea bream was 45.0%.
Most on-growing units use round-shaped cages with an excep-
tion of two units using square-shape cages. The cage diameter ranged 
from 12 to 50 m (mean = 29, median = 25, SD = 11) for the round-
shaped cages. Cage maximum biomass density ranged from 1.77 to 
23 kg/m3 (mean = 11, median = 10, SD = 4.7) for sea bass, and from 8 
to 70 kg/m3 (mean = 21, median = 15, SD = 19.8) for sea bream.
The relationships between ‘% mortality by pathogen’ and se-
lected management characteristics were visualized using boxplots 
for categorical variables, and scatter plots for continuous variables 
(Figures 3 and 4, respectively). Seabream appeared to have a higher 
median mortality than sea bass (Figure 3, panel a); however, there 
was a considerable variation within the two groups, and more data 
is needed for further analyses. The last two years (2016 and 2017) 
tended to have a somewhat higher mortality than 2015 (Figure 3, 
panel b), although uneven numbers of reported batches with dis-
ease may be influential for any significant difference. Within a year, 
the rising spring temperatures and high summer temperatures ap-
peared to correlate with more frequently reported disease occur-
rences (Figure 3, panel c). The data supported a higher mortality 
rate in batches that are ‘bought’ compared to self-cultured supply 
(Figure 3, panel d), as well as that batches that have undergone 
treatments for the diseases in the study period show the highest 
mortality (Figure 3, panel e). Sites that do not practice grading ap-
peared to have the highest mortality compared to those that use 
manual or automatic grading (Figure 3 panel f). However, more data 
would be required in order to assess the differences for statistical 
significance.
There was an indication of a correlation between increasing cage bio-
mass density and increasing mortality (Figure 4, panel d) while no such 
Statistical
% survival end of period % mortality by pathology
% mortality by other 
causes
Sea bass Sea bream Sea bass Sea bream Sea bass Sea bream
n 67 58 55 44 55 44
Mean 84.2 80.8 10.3 9.6 6.6 10.5
SD 10.1 7.7 9.2 6.2 5.4 7.1
Median 85.0 80.0 10.0 10.0 5.0 10.0
Q3-Q1 15.0 4.5 13.0 9.7 5. 11.5
Mode 80.0 80.0 15.0 10.0 5.0 5.0
Minimum 64.0 58.4 0.0 0.0 0.0 1.0
Maximum 100.0 99.0 36.0 18.0 24.6 27.2
p .074 .823 .003
Note: Sig. (p) U de Mann–Whitney.
TA B L E  3   Survival (%) at the end of the 
on-growing period, and mortalities (%) 
due to diseases and other causes (%), for 
sea bass and sea bream. n is the number 
of cohorts put to sea (Source: Fish-Farm 
Survey)
     |  7MUNIESA Et Al.
effect was seen for size of juveniles at sea transfer (Figure 4, panel c). Cage 
size did not show to be correlated with a reduced mortality (Figure 4, panel 
a), and increasing cage diameter appeared to correlate, although not sig-
nificantly with a somewhat reduced mortality (Figure 4, panel b).
3.7 | Geographical maps of main reported diseases
Disease occurrence was further investigated in relation to their 
geographical distribution by region. Figures 5 and 6 show the 
F I G U R E  3   Distribution of % 
mortality due to pathology by various 
explanatory variables (total number of 
observations = 78)
(a) (b)
(d)(c)
(e) (f)
F I G U R E  4   Scatter plots between % 
mortality due to diseases and various 
continuous explanatory variables
(a) (b)
(d)(c)
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geographical distributions of the reported diseases in sea bass and 
sea bream, respectively. For sea bass, the region having the highest 
disease occurrence was western Mediterranean with 101 records 
followed by eastern (74), central (63), southern (31) and outer (2) 
Mediterranean, respectively. Vibriosis was found in all regions and 
was the most reported disease by three regions (western, southern 
and eastern Mediterranean). Tenacibaculosis was mostly reported by 
central Mediterranean, but also reported from eastern and western 
F I G U R E  5   Maps showing the geographical distribution of reported diseases in sea bass according to disease survey data (2015–2017)
F I G U R E  6   Maps showing the geographical distribution of reported diseases in sea bream according to disease survey data (2015–2017)
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Mediterranean as well. Photobacteriosis was reported by both west-
ern and eastern Mediterranean. VER-VNN was reported by western, 
southern and eastern Mediterranean. A lower number of disease 
occurrences, and a different disease ranking, were observed in sea 
bream. The frequency of disease occurrences in southern, central, 
western, outer and eastern Mediterranean were 53, 50, 24, 15 and 
4, respectively. Sparicotyle was most frequently reported and was 
found in all regions. Winter syndrome was reported by western and 
central Mediterranean. Western Mediterranean was the only region 
to report VER-VNN.
4  | DISCUSSION
Seabass and seabream are the main species produced in 
Mediterranean marine fish farming, with a production of 426,744 
tonnes in 2017 (FAO, 2018). However, they, as other marine farmed 
species (e.g. meagre, sole, tuna), are not listed as susceptible host 
species for the notifiable pathogens listed in the current EU legisla-
tion (Council Directive 2006/88/EC) (EU, 2006), which generates a 
lack of systematic reporting for this sector. Most of the knowledge 
describing diseases in the sector comes from literature reporting di-
agnosed outbreaks of different pathogens and subsequent research 
on different related aspects, as well as from consultation with fish 
pathologists (Vendramin et al., 2016). Given these sources, it is dif-
ficult to get an accurate overview of the prevalence and distribution 
of those main, described diseases.
This study provides a necessary, new and complementary ap-
proach for determining the presence of diseases at a regional scale. 
Moreover, it also provides information about the survival and mor-
tality rate at the farm level, something not yet reported for the 
seabass and seabream sector. The Council Directive 2006/88/EC 
includes the obligation of notifying increases in mortality in aqua-
culture animals, to the competent authority or a private veterinar-
ian for further investigations. However, the definition of ‘increased 
mortality’ leaves space for interpretation, as the Directive define 
this term as ‘unexplained mortalities significantly above the level of 
what is considered to be normal for the farm or mollusc farming area 
in question under the prevailing conditions. What is considered to 
be increased mortality shall be decided in cooperation between the 
farmer and the competent authority’.
The mortality pattern of farmed fish populations is an import-
ant indicator of their health status. An abnormal increase should 
prompt investigations into the cause of mortality and mitigating 
measures should be implemented in order to prevent potential 
spread of an infection and maximize the survival rate for every 
production cycle. Seabass showed a higher survival rate (85.0%) 
through a production cycle than seabream (80.0%) in spite of 
equal mortality due to pathogen infections (10.0%; Table 3). The 
difference is explained by mortality ‘of other causes’ (non-patho-
gen infections) which is highest for sea bass; however, this cate-
gory is not defined further and cannot be further explained by our 
data. Besides the mean survival rates themselves, in seabass and 
seabream present respectively a standard deviation (SD) of 11.1 
and 7.6, with minimum survival of about 64.0% and maximum of 
100.0%. These data not only provide some information about av-
erage mortality/survival rates, but also points out that many farms 
in the Mediterranean have room for a significant improvement to 
reduce their mortality rates.
The production of sea bream and sea bass is not homogeneously 
distributed between the Mediterranean countries and this could be 
a confounding factor for the figures in Table 3. Thus, to properly 
evaluate differences in survival between these two species, it is 
necessary to stratify by country and species in order to assess such 
confounding. More accurate results would, however, require a larger 
dataset (sample size) than the number of consulted farms of this 
work (50 units). Thus, caution is needed when drawing conclusions 
based on the findings of this report.
It is pointed out that the number of consulted farms (50), from 
27 companies, was lower than the number initially planned, as some 
companies (9) were reluctant to participate arguing confidentially 
reasons. At the regional level, the information obtained by MedAID 
about prevalence of diseases (coming from surveyed farms) is in ac-
cordance with the information annually compiled by the European 
Union Reference Laboratory (EURL) through consultation with a 
group of fish pathologists. In the case of Spain the results of this 
study are quite similar to those available by the Spanish Federation 
of Health Protection Groups (FEADA), which are reported by asso-
ciated companies to the veterinarians of the different of the Health 
Protection Groups (J. López, FEADSA coordinator, personal com-
munication). Thus, although the sample size of this study was lower 
than initially planned, the results are believed to be representative 
and gives an improved picture of the prevalence and distribution of 
diseases in Mediterranean aquaculture.
The reluctance by a part of the sector to participate in the 
MedAID study, exemplifies a potential difficulty that administrations 
could face if seeking to implement disease surveillance programmes 
for seabass and seabream, which up to date are not listed as suscep-
tible host species for the notifiable pathogens listed in the current 
European legislation (Council Directive 2006/88/EC). Besides that 
possible reluctance, it was noticed that some farms do not keep ad-
equate health records and do not differentiate between mortality 
rates for diseases or other causes. Moreover, there is no common 
interpretation of what an ‘increased mortality’ may be (‘…shall be de-
cided in cooperation between the farmer and the competent author-
ity’), which reduces compliance with the above mentioned Directive.
For seabass, we found bacterial infections, especially vibrio-
sis and pasteurellosis, to be the dominant problems. A potential 
‘newcomer’ or emerging infection may be tenacibaculosis, which 
was reported especially from the western and central part of the 
Mediterranean. Our study does not cover a sufficient time period 
to indicate if this is a new, emerging trend. While tenacibaculosis, 
photobacteriosis and vibrioses were also reported from seabream, 
the great majority of cases were in hatcheries as opposed to in the 
on-growing stage as was seen for sea bass. As reviewed by Toranzo, 
Magariños, and Romalde (2005), economically important bacterial 
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infections in Gilthead sea bream and European sea bass include te-
nacibaculosis, photobacteriosis and vibriosis. Gilthead sea bream 
were additionally reported to be affected by pseudomonadiasis 
(Toranzo et al., 2005), while streptococcosis and mycobacteriosis, as 
well as Rickettsia-like organisms, were reported to affect sea bass 
(Toranzo et al., 2005). More recently, the bacteria causing furuncu-
losis in salmonids and turbot, Aeromonas salmonicida subsp. salmoni-
cida, has been isolated from farmed seabass in the Mediterranean 
coast of Spain (Fernández-Álvarez, Gijón, Álvarez, & Santos, 2016). 
A study specifically investigating bacterial infections in farmed sea 
bass in Spain found V. harveyi and V. splendidus to be most abundant, 
followed by V. ichthyoenteri-like isolates, Photobacterium damselae 
ssp. damselae and V. fisheri (Pujalte, Sitjà-Bobadilla, Álvarez-Pellitero, 
& Garay, 2003). It is hoped that future studies can shed further light 
on the prevalence of these bacterial pathogens in the Mediterranean 
sea bass and sea bream farms. The bacteria causing these infections 
are all indigenous in the seawater environment.
The viral disease VER-VNN occurs all over the Mediterranean 
as the dominant viral disease (Bovo et al., 2011; Haddad-Boubaker 
et al., 2013; Le Breton, Grisez, Sweetman, & Ollevier, 1997). While 
in our study it was mostly reported in the on-growing phase of 
sea bass and less frequently as a hatchery problem, it was only 
reported in the hatchery phase for sea bream. While informa-
tion from the EURL Fish meeting appears to suggest that VER-
VNN is decreasing in importance care should be taken given the 
scarcity of available official data. As there were no commercially 
available vaccines against nodavirus for seabass or seabream at 
the time of writing this paper, the lack of effective treatment op-
tions in the event of infection, surveillance for VER-VNN should 
be considered.
Our findings, based on farm data, are in concordance with the 
opinions of experts and the National Reference Laboratories for 
Fish Diseases, as reported at the Annual meeting organized by the 
EURL Fish in 2018 (Vendramin, 2018). For European seabass, te-
nacibaculosis was considered the most important disease followed 
by vibriosis (Vibrio spp.), with VER-VNN ranked third (as opposed 
to the previous year (2017) when this was considered the most 
important disease). For Gilthead sea bream, parasitic infections by 
S. chrysophrii (a gill fluke) is ranked first, followed by ‘red rash’ (un-
known aetiology), with VER-VNN again being assigned third rank 
(Anonymous, 2018).
Both our survey data and expert opinion from the EURL Fish 
meetings show the other major infectious agent affecting the in-
dustry to be the parasitic gill fluke infection (S. chrysophrii) in sea 
bream, which occurs throughout the year although there may be 
some seasonal variation. In 2017 the EURL experts ranked the gill 
fluke as the most important infectious agent for the industry as a 
whole and as the most important disease in sea bream specifically. 
The importance of this parasite in seabream production in Spain 
has previously been highlighted in the scientific literature (Sitjà-
Bobadilla, Redondo, & Alvarez-Pellitero, 2010). Gill infections in 
general may reduce growth rate and make the fish vulnerable to 
stress due to, for example, handling and environmental challenges 
and may be the underlying cause of mortalities reported in the 
category ‘other causes’.
This suggests that there may be a need for more knowledge 
on how to effectively control S. chrysophrii - infection, particularly 
in sea bream farms. Most parasites are normally present in small 
number on their hosts. Intensive farming in an area gives an in-
creasing number of fish and high densities will drive the burden of 
parasites in the area and increase exposure to hosts; both farmed 
and susceptible wild fish (Jansen et al., 2012). Parasites are chal-
lenging to control, as vaccines have been difficult to develop and 
parasites develop resistance to frequently applied chemical treat-
ments. An example of this is Atlantic salmon farming where chal-
lenges in controlling salmon lice (a copepodite) is one of the major 
obstacles for further growth of the industry (Hjeltnes et al., 2018). 
Sustainable control of S. chrysophrii - infection should therefore be 
given highest priority.
The sea bream and sea bass production in the Mediterranean 
is mainly based on hatchery produced fingerlings. The use of wild 
caught fingerlings is minor and only practiced in a few locations (e.g. 
Egypt). The MedAID project has estimated the balance between sup-
ply and demand for fingerlings in the region and found fingerlings to 
be a transboundary trading commodity. Fingerlings are transported 
across the Mediterranean basin, with France and Greece being the 
two countries with the biggest surplus for export. This situation 
highlights the need for transparent systems to prevent the potential 
spread of infectious diseases from hatcheries. Such systems should 
include well-documented and de facto high-level biosecurity and 
sanitary condition in hatcheries. Additionally, there is a need for 
health services, transparency of important disease information and 
harmonized procedures across the countries to provide trustworthy 
and reliable data and diagnostics.
It is worth noting that our data show that batches of fish which 
are ‘self-cultured’ show a lower mortality rate due to pathogens than 
batches brought to the farm by external trade. If connected to a high 
transboundary trade activity of fingerlings, this further emphasizes the 
need for reliable and harmonized animal health management systems.
Maximum biomass density (kg/m2 water) is often used as a 
welfare indicator. In our data there was a correlation between this 
density variable and mortality by pathogens. This effect was not re-
flected in cage size, but tended to be more correlated to surface area 
of the cage. It should be noted that this tendency of correlation was 
based on univariate comparison, and testing for significant associa-
tion using univariable regression analysis and multivariable analysis 
should be next step.
Conclusions from the two independent data sources, MedAID 
survey and EURL Fish, are supportive of each other, suggesting that 
the data reflect the real disease situation for the seabream and sea-
bass aquaculture industry in the Mediterranean. The MedAID sur-
vey provides information about the distribution of diseases, as well 
as the survival/mortality rates, a Key Performance Indicator that 
can help competent authorities in the implementation of Council 
Directive 2006/88/EC. Despite of this the need for caution when 
interpreting these data should be emphasized.
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For both data sources, there are relatively few participants sup-
plying data. Even more important, the farms may have different 
systems for recording and keeping disease data and diagnoses, and 
diagnostic procedures are not harmonized across all laboratories and 
countries. Disease reporting may also be missing as an issue relating 
to company reputations. In our study, it was also difficult to separate 
between outbreaks with long-lasting impact compared to new or 
shorter duration outbreaks.
One should also take into account that increased focus and 
awareness on diseases in itself may create more diagnoses. A higher 
number of a specific diagnosis may therefore just reflect higher 
competence and academic profiles with increased interest in disease 
research. These issues underlines the cautious approach needed to 
these data and their results.
An EFSA risk assessment of sea bass and sea bream aquaculture 
concluded that the majority of the farms were monitoring health to 
a high standard (EFSA, 2008). As the current legal framework does 
not provide the basis for an official harmonized reporting of the rel-
evant pathogens in the Mediterranean basin, improved reporting of 
the disease status of aquaculture farms in the region may not be sim-
ple to implement. It is hoped that the findings of this study provide 
additional background information in order to aid the development 
of improved disease data collection to facilitate the growth of the 
Mediterranean aquaculture industry.
5  | CONCLUSIONS
Seabream and seabass have different disease profiles, which 
also differ according to production systems/phases (on-growing/
hatcheriey) and geographical regions. As a result, they should be 
monitored separately and both geographical factors and produc-
tion characteristics should be further investigated. Among the 
most important diseases identified were tenacibaculosis and vi-
briosis in sea bass and S. chrysophrii (a gill fluke) and nodavirus in 
sea bream.
Currently, farms do not keep and/or report sufficient quality 
data to ensure high quality health status reports of Mediterranean 
sea bass and sea bream aquaculture. Detailed disease impact stud-
ies should be performed and the risk analysis approach needs to be 
taken on board in the Mediterranean basin aquaculture to provide 
technical based guidance for its improvement. There is also a need 
to conduct further studies to better determine what should be un-
derstood for normal mortality/survival rates, which should also con-
sider different productions systems and/or phases. It is necessary 
to define how to measure mortality rate at a farm scale (farm, batch, 
time scale, etc.), in order to better apply the current regulation, 
which demands the communication of ‘increased mortality’ events.
While VER-VNN was reported less frequently than bacterial dis-
ease in our dataset. Its potential economic importance, coupled with 
the lack of available prevention and treatment measures, suggests 
that this should be a prioritized agent for surveillance programs in 
the Mediterranean region.
Transparent knowledge and information sharing are essen-
tial for the running of a sustainable aquaculture production in the 
Mediterranean basin. Transportation of live animals is common 
practice in the whole Mediterranean basin and impose a great risk, if 
there is a lack of control and biosecurity measures.
Of primary importance is the need for harmonized diagnostic 
procedures and a standardized recording and reporting of a set of 
critical disease data in order to get a representative picture of the 
disease situation in the Mediterranean aquaculture industry. Such a 
system is crucial for developing biosecurity and contingency plans at 
company, industry and national level.
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